Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29488607 | 0.95 | CES2 (0.33) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488586 | 0.95 | CES2 (0.37) | PLA2G4BALDH1A1CES2HPGDGMNN | |
| SCHEMBL29488601 | 0.94 | CES2 (0.36) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488597 | 0.94 | CES2 (0.36) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488611 | 0.94 | CES2 (0.36) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488602 | 0.94 | CES2 (0.36) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488610 | 0.94 | CES2 (0.36) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488596 | 0.94 | CES2 (0.36) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488598 | 0.94 | CES2 (0.36) | PLA2G4BALDH1A1CES2GMNNTP53 | |
| SCHEMBL29488606 | 0.94 | PLA2G4B (0.31) | PLA2G4BALDH1A1CES2HPGDGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4001359-B1 | SULPHUR-LINKABLE RUBBER COMPOUND, VULCANIZATE OF THE RUBBER COMPOUND AND VEHICLE TYRES | CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) | 2025-09-03 | — | — | EP | disclosed |
| US-11542286-B2 | Silane mixtures and process for preparing same | EVONIK OPERATIONS GMBH (DE) | 2023-01-03 | — | — | US | disclosed |
| CN-111386199-B | Sulfur-crosslinkable rubber mixture, vulcanized rubber of rubber mixture and vehicle tire | 大陆轮胎德国有限公司 | 2022-05-31 | — | — | CN | disclosed |
| EP-4001359-A1 | SULPHUR-LINKABLE RUBBER COMPOUND, VULCANIZATE OF THE RUBBER COMPOUND AND VEHICLE TYRES | Continental Reifen Deutschland GmbH (DE) | 2022-05-25 | — | — | EP | disclosed |
| CN-109971034-B | Silane mixture and method for the production thereof | 赢创运营有限公司 | 2022-03-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11542286-B2 | Silane mixtures and process for preparing same | MSR1, SRM, SPEN | PLA2G4B 4111/4885ALDH1A1 4119/4885CES2 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.